4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-26-015769
President and CEO sold 1,663 shares at $431.94 ($718,316)
- President and CEO acquired 14,995 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sibold William John President and CEO | 2026-03-04 | Grant or award | +14,995 | 163,492 | D | ||
| Sibold William John President and CEO | 2026-03-06 | Sale | −1,663 | $431.94 | $718,316 | 161,829 | D |
| Derivatives | |||||||
| Sibold William John President and CEO | 2026-03-04 | Grant or award · Stock Option (Right to Buy) | +18,743 | 18,743 | D | ||
| Open-market sales · 1,663 sh · avg $431.94 · $718,316 | |||||||
Loading xslF345X05/wk-form4_1772840956.xml…